We are live on ! Find out more
SGTX

Sigilon Therapeutics, Inc. Common Stock
SGTX

Delisted

SGTX was delisted on the 10th of August, 2023.

Back to rankings

45 hedge funds and large institutions have $942M invested in Sigilon Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
0.8%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
+$362M
2
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$51.8M
3
BlackRock
BlackRock
New York
+$38.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$33.3M
5
HP
Harbourvest Partners
Massachusetts
+$25.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PVI
26
Pura Vida Investments
New York
$1.19M +$863K +1,902 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$813K +$591K +1,302 New
ECM
28
ExodusPoint Capital Management
New York
$780K +$567K +1,250 New
ZP
29
Zimmer Partners
New York
$720K +$524K +1,154 New
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$676K +$491K +1,082 New
PTC
31
Philadelphia Trust Company
Pennsylvania
$655K +$476K +1,050 New
LCM
32
Laurion Capital Management
New York
$480K +$349K +769 New
DKCM
33
Davidson Kempner Capital Management
New York
$474K +$349K +769 New
Citigroup
34
Citigroup
New York
$457K +$333K +733 New
SG Americas Securities
35
SG Americas Securities
New York
$375K +$272K +600 New
Tudor Investment Corp
36
Tudor Investment Corp
Connecticut
$370K +$269K +592 New
Norges Bank
37
Norges Bank
Norway
$360K +$262K +577 New
MFS
38
Mirabella Financial Services
United Kingdom
$343K +$249K +549 New
ZDA
39
Zweig-DiMenna Associates
New York
$298K +$216K +477 New
MS
40
Maven Securities
Jersey
$255K +$186K +409 New
PHK
41
Point72 Hong Kong
Hong Kong
$201K +$146K +322 New
Morgan Stanley
42
Morgan Stanley
New York
$155K +$113K +249 New
HPC
43
HM Payson & Co
Maine
$49K +$35.8K +79 New
UBS Group
44
UBS Group
Switzerland
$25K +$18.1K +40 New
VFA
45
Valeo Financial Advisors
Indiana
$5K +$4.08K +9 New
1
2

SGTX Hedge Fund Activity: Q4 2020 in Review

45 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Sigilon Therapeutics, Inc. Common Stock (SGTX) for Q4 2020, worth a combined $942M.

Buyers outnumbered sellers: 45 funds opened new SGTX positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Flagship Pioneering, opening a new position worth an estimated $362M.

  • 45 institutional investors held Sigilon Therapeutics, Inc. Common Stock (SGTX) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $942M of Sigilon Therapeutics, Inc. Common Stock stock for Q4 2020.
  • 45 funds opened new Sigilon Therapeutics, Inc. Common Stock positions in Q4 2020 and 0 closed out, a net change of +45 holders.
  • The largest Sigilon Therapeutics, Inc. Common Stock buyer in Q4 2020 was Flagship Pioneering, an estimated $362M added.

Based on aggregated 13F filings for Q4 2020.